NEW YORK, March 14 - PamGene, a Dutch microarray startup, and Olympus Optical have agreed to jointly develop a platform for manufacturing and analyzing DNA microarrays, the companies said Wednesday.

As part of the alliance, Olympus has made a "significant" equity investment in PamGene, based in Den Bosch, the Netherlands. Exact financial details were not disclosed. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.